Edition:
United States

Biotechnology & Medical Research

Page 1

Replicel Life Sciences continues restructuring with share structure consolidation

Friday, 22 Jul 2016 09:20pm EDT

Replicel Life Sciences Inc : Replicel Life Sciences continues restructuring with share structure consolidation .Says its board of directors has authorized a plan to proceed with a consolidation of its outstanding common shares.

Replicel Life Sciences continues restructuring with share structure consolidation

Friday, 22 Jul 2016 07:05pm EDT

Replicel Life Sciences Inc : Replicel Life Sciences continues restructuring with share structure consolidation .Says its board of directors has authorized a plan to proceed with a consolidation of its outstanding common shares.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Analyst Research

Report Title Price
Provider : Thomson Reuters StreetEvents
$75.00
Provider : Thomson Reuters StreetEvents
$75.00
Provider : Edison Investment Research
$10.00
Provider : Thomson Reuters StreetEvents
$75.00
Provider : Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.